Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The Thematic Strategy was published in late 2005 and constitutes an important step in a series of initiatives that have contributed to the development of Europe’s policy on the urban environment. Given the diversity of urban areas and existing national, regional and local circumstances the Strategy does not dictate the solutions that cities should adopt as it would be impossible to propose a "one size fits all" approach. The Commission did however undertake to prepare, in consultation with cities and stakeholders, guidance on sustainable urban transport planning and integrated environmental management. The objectives of the Strategy have, and continue to be, supported by Community funding programmes (see later) | WHO Guidelines for Pharmacological Management of Pandemic Influenza A H1N1 2009 and other Influenza Viruses Revised February 2010 Part I Recommendations World Health Organization Pharmacological Management of Pandemic Influenza A H1N1 2009 Part I Recommendations Contents CONTENTS.2 SUMMARY.3 1. INTRODUCTION.4 2. CASE DESCRIPTION.5 3. RISK GROUPS.6 4. EPIDEMIOLOGY.7 5. GENERAL CONSIDERATIONS.8 6. RECOMMENDATIONS.10 6.1 Use of antivirals for treatment of pandemic influenza A H1N1 2009 virus infection in adults and adolescents.10 6.2 Use of antivirals for treatment of uncomplicated pandemic influenza A H1N1 2009 virus infection in adults and adolescents.14 6.3 Use of antivirals for treatment of pandemic influenza A H1N1 2009 virus infection in children.15 6.4 Use of antivirals where antiviral resistance is known or suspected.17 6.5 Antiviral treatment recommendations Other influenza virus strains.18 6.6 Use of antivirals for chemoprophylaxis of pandemic influenza A H1N1 2009 virus infection.19 6.7 Other considerations.20 7. OTHER INTERVENTIONS FOR MANAGEMENT OF PATIENTS WITH INFLUENZA.20 8. PRODUCT SUPPLY. 24 9. PRIORITIES FOR UPDATE.25 Plans for updating this guideline. 25 Updating or adapting recommendations locally.25 10. PRIORITIES FOR RESEARCH.26 ANNEX 1 RISK FACTORS FOR SEVERE DISEASE.27 ANNEX 2 LIST OF PARTICIPANTS.28 ANNEX 3 DECLARATIONS OF INTERESTS. 30 ANNEX 4 TABLE OF STANDARD DOSAGES.32 Pharmacological Management of Pandemic Influenza A H1N1 2009 Part I Recommendations Summary This guidance updates and replaces the recommendations published in August 2009. This document will again be reviewed in September 2010 and if necessary updated. Key changes to the guidelines are Simplification of recommendations as pandemic influenza A H1N1 2009 virus has become the predominant influenza virus worldwide. Specific guidance for the treatment of young children from birth including guidance on dose and formulation Recommendations 06-08 . Additional guidance for .
